Table 45.

Antidiabetic potential of the compounds (ad34–ad35) in alloxan-induced diabetes in rats.

Comp.	% Decrease in Plasma Glucose Level (PG) at Various Drug Doses (mg/kg Bodyweight)
	10 mg	30 mg	100 mg
ad34	42.48 ± 3.25	62.24 ± 3.42	70.35 ± 3.14
ad35	45.42 ± 1.25	58.36 ± 2.36	68.42 ± 2.16
Pioglitazone	47.25 ± 5.50	64.59 ± 5.42	75.43 ± 3.40

(N = 6) all data sare given as mean ± SEM value.